Laboratory Predictors of Hemorrhagic Complications in Patients With Total Hip Arthroplasty and Treatment With Direct Oral Anticoagulants

Laboratory Predictors of Hemorrhagic Complications in Patients With Total Hip Arthroplasty and Treatment With Direct Oral Anticoagulants

Introduction. Direct oral anticoagulants (DOAC) rivaroxaban and apixaban have significantly reduced the risk of developing venous thromboembolic complications (VTEC). However, the use of DOAC may be associated with a higher risk of bleeding, especially actual in patients after total hip arthroplasty...

Full description

Saved in:
Bibliographic Details
Main Authors: L. B. Gaikovaya, K. N. Zamyatina, A. N. Tkachenko, I. L. Urazovskaya, D. Sh. Mansurov, A. G. Balgley, V. M. Khaidarov, B. G. Aliyev
Format: Article
Language:Russian
Published: Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department 2023-11-01
Series:Неотложная медицинская помощь
Subjects:
rivaroxaban
apixaban
total hip arthroplasty
hemostasis
bleeding
Online Access:https://www.jnmp.ru/jour/article/view/1669
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.jnmp.ru/jour/article/view/1669

Similar Items